Psilocybin (Revive Therapeutics)

赛洛西宾 (Revive Therapeutics)

Report date: 2026/05/13 20:02:10

Base Information

Drug NamePsilocybin (Revive Therapeutics)
Drug Alias Name裸盖菇素Psilocybin (Microneedle Patch)Psilocybin (Oral Capsule)PSY-0.1PSY-0.2 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsAnxietyDepressionSubstance-Related Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPsilocin Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesRevive Therapeutics Ltd
Inactive CompaniesUniversity Of Wisconsin-Madison
Active IndicationsAnxietyDepressionSubstance-Related Disorders
Inactive IndicationsChemically-Induced Disorders

Other Information

ATC CodeN/A
Related LinksN/A